Jacob Van Naarden
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jacob Van Naarden
Jacob Van Naarden is recorded as CEO at ELI LILLY & Co (LLY). The proxy statement of ELI LILLY & Co reports total compensation of $6,122,742 for Jacob Van Naarden in fiscal 2021, including a base salary of $745,649.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ELI LILLY & Co
Other people whose current roles at this company are on record from its filings.
- Juan Luciano CEO
- David Ricks Chairman, Board Member
- Kimberly Johnson COO
- Anat Hakim General Counsel
- Carolyn Bertozzi Board Member
- Carolyn R. Bertozzi Board Member
- Dr. Mary Lynne Hedley Board Member
- Jon Moeller Board Member
- William Kaelin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | ELI LILLY & Co (LLY) | Senior Vice President, CEO Loxo Oncology at Lilly and President, Lilly Oncology | $745,649 | $6,122,742 |
Recent activity
No call appearances or filed executive changes recorded yet.